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Given the confusion and strong opinions surrounding 
goal-directed therapy (GDT), Lees and colleagues [1] 
have done a commendable job of clearly deﬁ  ning GDT 
and how it pertains to each clinical setting as well as 
separately examining the individual bodies of relevant 
literature. Th  e authors separate the physiologic and 
patho  physiologic discussion of both the perioperative 
and septic patient populations, thus contextualizing 
diﬀ  er  ent approaches to both volume and hemodynamic 
GDT. Despite the encouraging body of literature in the 
early days of oxygen-targeted approaches to early GDT 
(oxygen delivery [DO2] of greater than 600 mL/min per m2) 
[2-4], more recent studies have not conﬁ  rmed these results 
[5,6]. Much speculation and controversy  surrounds this 
technique, where it appears that no beneﬁ  t, if not worse 
outcomes, are being observed in patients with established 
sepsis. Conversely, measurable beneﬁ   ts have been 
observed in the perioperative setting, though not in all of 
the published studies.
Recent interest surrounds the work of Rivers and 
colleagues [7], in which a signiﬁ  cant mortality reduction 
was observed in patients admitted with septic shock to 
the emergency department. Patients were randomly 
assigned to either standard-of-care treatment or a multi-
faceted early GDT algorithm, incorporating volume 
optimization, blood, and inotropes. Major criticisms of 
the study are that it was single-center with relatively 
small numbers and with a high mortality rate in the 
control group (considering the APACHE II [Acute 
Physiology and Chronic Health Evaluation II] scores), 
and no subsequent studies have yet replicated these 
results. A large multicenter randomized controlled study 
(studying almost 2,000 patients), called the ProCESS 
(Protocolized Care for Early Septic Shock) Study 
(ClinicalTrials.gov number NCT00510835), is currently 
under way, examining this technique in greater detail.
Th  e major controversy in the perioperative setting is 
whether to maximize stroke volume or to restrict ﬂ  uids. 
Th  ese bodies of literature appear to be completely 
contradictory in their techniques, usually leaving the 
clinician confused. With a number of randomized 
controlled trials published, there is little doubt that stroke 
volume optimization is a good thing, albeit that all 
published studies are single-center eﬀ   orts [8]. Th  e 
restrictive studies have all used diﬀ  erent strategies for 
restricting the total volume of ﬂ  uids administered, with 
results ranging from improved outcomes through no 
diﬀ   erence to worse outcomes with restrictive practice 
[9,10]. It is extremely unfortunate that the name 
‘restriction’ was chosen early on in this body of literature 
as the true technique guides a relative ﬂ  uid restriction to 
prior techniques rather than an absolute restriction in 
volume. A more suitable term is ‘avoidance of crystalloid 
excess’, which is the key to improving outcomes. Th  ese 
two approaches can be complementary, when a judicious 
volume of crystalloid is administered (that is, ‘restrictive’ 
approach) combined with a stroke volume-targeted 
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Th   is all leaves us wondering what technology we should 
use. For pure volume optimization, the esophageal 
Doppler monitor has the largest body of evidence to 
guide its use [11-13]. Its relatively steep and diﬃ   cult 
learning curve has probably been its Achilles heel, slow-
ing adoption somewhat; however, its incorporation into 
the Enhanced Recovery After Surgery (ERAS) program is 
currently a strong driving force for renewed interest. An 
alternative approach is arterial waveform-derived cardiac 
output monitoring, in which the intravascular volume 
responsiveness indices (for example, stroke volume 
variation and pulse pressure variation) appear to be 
capable of providing acceptable data for guiding ﬂ  uid 
management in mandatory ventilated patients [14]. It is 
important to note that there are currently only a couple 
of studies showing that oxygen-targeted approaches [15] 
or volume optimization [16] with these monitors 
improves outcomes. Th   e current distinct lack of pertinent 
research in this area makes diﬃ   cult any recommendation 
regarding universal adoption of these waveform-based 
technologies.
Th   e big question is: what should we do, or how should 
we go about early GDT? We believe that carefully 
managed crystalloids, following the ‘restrictive’ principles 
and accounting for crystalloid needs, is the ﬁ  rst 
important step. Early, simple algorithmic, stroke volume-
targeted colloid ﬂ   uid administration is the second 
important step, guiding both the administration and the 
pausing of colloid intravenous ﬂ  uids.
So should we then use oxygen-targeted approaches? 
Although the groups of Shoemaker [2], Boyd [3], Wilson 
[4], and Pearse [15] have all shown improved outcomes 
with these types of approaches, it is the dissention of 
groups showing no diﬀ  erence or worse outcomes that has 
clouded the water [5,6]. Despite unfavorable results in 
patients with advanced sepsis, it is likely that in addition 
to the above-mentioned ﬂ  uid management, the high-risk 
perioperative patient will beneﬁ  t from such approaches. 
Th   e target DO2 of 600 mL/min per m2 of Shoemaker and 
colleagues [2] could still be ideal, but it seems prudent to 
individualize each patient’s target based on their speciﬁ  c 
physiologic proﬁ   le, something we should gain greater 
understanding of over the next few years, with cardio-
pulmonary exercise testing driving the type and extent of 
therapy. Furthermore, we currently have no useful 
monitor of tissue ‘well-being’, which could be invaluable 
in the delivery of GDT. Tissue oximetry may be of beneﬁ  t 
but is still a long way from being a routine monitor.
Clearly, our practice needs to be guided to optimizing 
tissues at risk (for example, the gut). When these tissues 
are struggling, our therapy needs to be escalated to meet 
the need and resuscitate these tissues. Should the risk 
have endured too long and tissues suﬀ  er  irreparable 
damage, the ﬁ  nal word belongs to Shoemaker. Following 
the publication of a large GDT study by Gattinoni and 
colleagues [6] in 1995, Shoe  maker [17] wrote a letter to 
the editor, stating: ‘…Gattinoni et al., like Hayes et al., have 
done us a service by pointing out the limitations of our 
approach, which clearly does not prevent organ failure 
and death in patients who already have established organ 
failure. We concur that it is impossible to resuscitate 
dead cells and failed organs, even with oxygen’.
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